UK and UK doctors warned not to rush to rush new vaccine to combat SMA
- by admin
A series of warnings from leading UK doctors has warned against rushing to vaccinate the millions of people with the SMA, the virus that causes the illness.SMA is caused by the coronavirus, and the first dose of the vaccine will be administered to people aged 16 and over.
Dr Joanne Meech, an infectious diseases specialist at London’s Queen Mary University of London, said there were still some things that needed to be ironed out.
“We’re still going to need to do some additional research, but the good news is the vaccine is in the pipeline and should be available in the next few months,” she said.
“We’ve been told the vaccine can prevent the virus from spreading further and people are getting the first shot and it’s just the right timing.”
The vaccine will protect against a range of SMA-related conditions including pneumonia, high fevers and respiratory infections.
Dr Meeech said there was still no evidence to suggest that the vaccine was effective in preventing the coronovirus from spreading.
But she said it was important to be cautious about taking the vaccine at this stage.
“I think that’s a bit like the old saying: don’t rush to judgment on anything.
You can’t say ‘this is what we know’, you have to look at the evidence,” she explained.
“[The vaccine] is being delayed by a little bit because there are a lot of things to be looked at.”
So we need to be aware of what we’re doing, how we’re planning and what we expect from the vaccine and what’s going to happen when it comes in.
“Dr Mowat said people could be advised to wait a few weeks after receiving the vaccine before trying to get vaccinated.
Dr Pauline O’Connor, a specialist in infectious diseases at University College London, agreed that there was a lot more work to be done to make sure the vaccine worked well.”
There’s no doubt there’s still a lot to be learnt about SMA and we need more data to really sort that out,” she told ABC News.
A spokesman for Health Minister Andrew Lansley said the Government was reviewing the vaccine’s safety and efficacy.
He said the vaccine would be available to all UK people between the ages of 16 and 75 by the end of the year.”
This is part of our commitment to deliver the best possible vaccine for people who live in the UK and the best chance of preventing further cases of SME in the coming years,” the spokesman said.
Lansley said he was concerned that the virus could spread in the community and that there were fears it might affect people with co-morbid conditions.
In the UK, about 10,000 people are infected with the coronivirus each year, and in the United States, about 20,000.
The virus has killed more than 5,000 and infected about 11,000, causing severe illness, death and disability.
It has infected more than 8 million people worldwide, and more than 10,500 have died.
A series of warnings from leading UK doctors has warned against rushing to vaccinate the millions of people with the…